Through SMT’s acquisition of Vascular Concepts, our portfolio now includes advanced structural heart therapies, including occluders and TAVR. These solutions broaden our ability to support interventional cardiologists and cardiac surgeons, offering more treatment options for congenital and structural heart disease while delivering accessibility and value for hospitals and patients.